Global DTaP and Tdap Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global DTaP and Tdap Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for DTaP and Tdap Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for DTaP and Tdap Vaccines by Country/Region, 2017, 2022 & 2028

2.2 DTaP and Tdap Vaccines Segment by Type

2.2.1 DTaP

2.2.2 Td

2.2.3 Tdap

2.3 DTaP and Tdap Vaccines Sales by Type

2.3.1 Global DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global DTaP and Tdap Vaccines Sale Price by Type (2017-2022)

2.4 DTaP and Tdap Vaccines Segment by Application

2.4.1 Adult

2.4.2 Pediatric

2.5 DTaP and Tdap Vaccines Sales by Application

2.5.1 Global DTaP and Tdap Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global DTaP and Tdap Vaccines Sale Price by Application (2017-2022)

3 Global DTaP and Tdap Vaccines by Company

3.1 Global DTaP and Tdap Vaccines Breakdown Data by Company

3.1.1 Global DTaP and Tdap Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Company (2020-2022)

3.2 Global DTaP and Tdap Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global DTaP and Tdap Vaccines Revenue by Company (2020-2022)

3.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global DTaP and Tdap Vaccines Sale Price by Company

3.4 Key Manufacturers DTaP and Tdap Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers DTaP and Tdap Vaccines Product Location Distribution

3.4.2 Players DTaP and Tdap Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for DTaP and Tdap Vaccines by Geographic Region

4.1 World Historic DTaP and Tdap Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global DTaP and Tdap Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global DTaP and Tdap Vaccines Annual Revenue by Geographic Region

4.2 World Historic DTaP and Tdap Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global DTaP and Tdap Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global DTaP and Tdap Vaccines Annual Revenue by Country/Region

4.3 Americas DTaP and Tdap Vaccines Sales Growth

4.4 APAC DTaP and Tdap Vaccines Sales Growth

4.5 Europe DTaP and Tdap Vaccines Sales Growth

4.6 Middle East & Africa DTaP and Tdap Vaccines Sales Growth

5 Americas

5.1 Americas DTaP and Tdap Vaccines Sales by Country

5.1.1 Americas DTaP and Tdap Vaccines Sales by Country (2017-2022)

5.1.2 Americas DTaP and Tdap Vaccines Revenue by Country (2017-2022)

5.2 Americas DTaP and Tdap Vaccines Sales by Type

5.3 Americas DTaP and Tdap Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC DTaP and Tdap Vaccines Sales by Region

6.1.1 APAC DTaP and Tdap Vaccines Sales by Region (2017-2022)

6.1.2 APAC DTaP and Tdap Vaccines Revenue by Region (2017-2022)

6.2 APAC DTaP and Tdap Vaccines Sales by Type

6.3 APAC DTaP and Tdap Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe DTaP and Tdap Vaccines by Country

7.1.1 Europe DTaP and Tdap Vaccines Sales by Country (2017-2022)

7.1.2 Europe DTaP and Tdap Vaccines Revenue by Country (2017-2022)

7.2 Europe DTaP and Tdap Vaccines Sales by Type

7.3 Europe DTaP and Tdap Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa DTaP and Tdap Vaccines by Country

8.1.1 Middle East & Africa DTaP and Tdap Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa DTaP and Tdap Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa DTaP and Tdap Vaccines Sales by Type

8.3 Middle East & Africa DTaP and Tdap Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines

10.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines

10.4 Industry Chain Structure of DTaP and Tdap Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 DTaP and Tdap Vaccines Distributors

11.3 DTaP and Tdap Vaccines Customer

12 World Forecast Review for DTaP and Tdap Vaccines by Geographic Region

12.1 Global DTaP and Tdap Vaccines Market Size Forecast by Region

12.1.1 Global DTaP and Tdap Vaccines Forecast by Region (2023-2028)

12.1.2 Global DTaP and Tdap Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global DTaP and Tdap Vaccines Forecast by Type

12.7 Global DTaP and Tdap Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur

13.1.1 Sanofi Pasteur Company Information

13.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Product Offered

13.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Main Business Overview

13.1.5 Sanofi Pasteur Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline DTaP and Tdap Vaccines Product Offered

13.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Protein Sciences Corporation

13.3.1 Protein Sciences Corporation Company Information

13.3.2 Protein Sciences Corporation DTaP and Tdap Vaccines Product Offered

13.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Protein Sciences Corporation Main Business Overview

13.3.5 Protein Sciences Corporation Latest Developments

13.4 Novartis AG

13.4.1 Novartis AG Company Information

13.4.2 Novartis AG DTaP and Tdap Vaccines Product Offered

13.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis AG Main Business Overview

13.4.5 Novartis AG Latest Developments

13.5 Seqirus

13.5.1 Seqirus Company Information

13.5.2 Seqirus DTaP and Tdap Vaccines Product Offered

13.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Seqirus Main Business Overview

13.5.5 Seqirus Latest Developments

13.6 Merck Sharp & Dohme Corp

13.6.1 Merck Sharp & Dohme Corp Company Information

13.6.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Offered

13.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Sharp & Dohme Corp Main Business Overview

13.6.5 Merck Sharp & Dohme Corp Latest Developments

13.7 Astellas Pharma US, Inc

13.7.1 Astellas Pharma US, Inc Company Information

13.7.2 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Offered

13.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Astellas Pharma US, Inc Main Business Overview

13.7.5 Astellas Pharma US, Inc Latest Developments

13.8 Pfizer Inc

13.8.1 Pfizer Inc Company Information

13.8.2 Pfizer Inc DTaP and Tdap Vaccines Product Offered

13.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Inc Main Business Overview

13.8.5 Pfizer Inc Latest Developments

13.9 Johnson & Johnson

13.9.1 Johnson & Johnson Company Information

13.9.2 Johnson & Johnson DTaP and Tdap Vaccines Product Offered

13.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Johnson & Johnson Main Business Overview

13.9.5 Johnson & Johnson Latest Developments

13.10 Lanzhou Institute of Biological Products Co., Ltd

13.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Information

13.10.2 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Offered

13.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Lanzhou Institute of Biological Products Co., Ltd Main Business Overview

13.10.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments

13.11 AstraZeneca

13.11.1 AstraZeneca Company Information

13.11.2 AstraZeneca DTaP and Tdap Vaccines Product Offered

13.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AstraZeneca Main Business Overview

13.11.5 AstraZeneca Latest Developments

13.12 Emergent BioSolutions Inc

13.12.1 Emergent BioSolutions Inc Company Information

13.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Offered

13.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Emergent BioSolutions Inc Main Business Overview

13.12.5 Emergent BioSolutions Inc Latest Developments

14 Research Findings and Conclusion

Table 1. DTaP and Tdap Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. DTaP and Tdap Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of DTaP

Table 4. Major Players of Td

Table 5. Major Players of Tdap

Table 6. Global DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)

Table 7. Global DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global DTaP and Tdap Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global DTaP and Tdap Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)

Table 12. Global DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global DTaP and Tdap Vaccines Revenue by Application (2017-2022)

Table 14. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global DTaP and Tdap Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global DTaP and Tdap Vaccines Sales by Company (2020-2022) & (K Units)

Table 17. Global DTaP and Tdap Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global DTaP and Tdap Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global DTaP and Tdap Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global DTaP and Tdap Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers DTaP and Tdap Vaccines Producing Area Distribution and Sales Area

Table 22. Players DTaP and Tdap Vaccines Products Offered

Table 23. DTaP and Tdap Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global DTaP and Tdap Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global DTaP and Tdap Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global DTaP and Tdap Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global DTaP and Tdap Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global DTaP and Tdap Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global DTaP and Tdap Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global DTaP and Tdap Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global DTaP and Tdap Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)

Table 35. Americas DTaP and Tdap Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas DTaP and Tdap Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)

Table 39. Americas DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)

Table 41. Americas DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)

Table 43. APAC DTaP and Tdap Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC DTaP and Tdap Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC DTaP and Tdap Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. APAC DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. APAC DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe DTaP and Tdap Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa DTaP and Tdap Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of DTaP and Tdap Vaccines

Table 67. Key Market Challenges & Risks of DTaP and Tdap Vaccines

Table 68. Key Industry Trends of DTaP and Tdap Vaccines

Table 69. DTaP and Tdap Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. DTaP and Tdap Vaccines Distributors List

Table 72. DTaP and Tdap Vaccines Customer List

Table 73. Global DTaP and Tdap Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global DTaP and Tdap Vaccines Sales Market Forecast by Region

Table 75. Global DTaP and Tdap Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas DTaP and Tdap Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas DTaP and Tdap Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC DTaP and Tdap Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC DTaP and Tdap Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe DTaP and Tdap Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe DTaP and Tdap Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa DTaP and Tdap Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa DTaP and Tdap Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global DTaP and Tdap Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global DTaP and Tdap Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global DTaP and Tdap Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global DTaP and Tdap Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Pasteur Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Pasteur DTaP and Tdap Vaccines Product Offered

Table 95. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Sanofi Pasteur Main Business

Table 97. Sanofi Pasteur Latest Developments

Table 98. GlaxoSmithKline Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. GlaxoSmithKline DTaP and Tdap Vaccines Product Offered

Table 100. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. GlaxoSmithKline Main Business

Table 102. GlaxoSmithKline Latest Developments

Table 103. Protein Sciences Corporation Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Protein Sciences Corporation DTaP and Tdap Vaccines Product Offered

Table 105. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Protein Sciences Corporation Main Business

Table 107. Protein Sciences Corporation Latest Developments

Table 108. Novartis AG Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Novartis AG DTaP and Tdap Vaccines Product Offered

Table 110. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Novartis AG Main Business

Table 112. Novartis AG Latest Developments

Table 113. Seqirus Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Seqirus DTaP and Tdap Vaccines Product Offered

Table 115. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Seqirus Main Business

Table 117. Seqirus Latest Developments

Table 118. Merck Sharp & Dohme Corp Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Offered

Table 120. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Merck Sharp & Dohme Corp Main Business

Table 122. Merck Sharp & Dohme Corp Latest Developments

Table 123. Astellas Pharma US, Inc Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Offered

Table 125. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Astellas Pharma US, Inc Main Business

Table 127. Astellas Pharma US, Inc Latest Developments

Table 128. Pfizer Inc Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. Pfizer Inc DTaP and Tdap Vaccines Product Offered

Table 130. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Pfizer Inc Main Business

Table 132. Pfizer Inc Latest Developments

Table 133. Johnson & Johnson Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Johnson & Johnson DTaP and Tdap Vaccines Product Offered

Table 135. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Johnson & Johnson Main Business

Table 137. Johnson & Johnson Latest Developments

Table 138. Lanzhou Institute of Biological Products Co., Ltd Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Offered

Table 140. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Lanzhou Institute of Biological Products Co., Ltd Main Business

Table 142. Lanzhou Institute of Biological Products Co., Ltd Latest Developments

Table 143. AstraZeneca Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 144. AstraZeneca DTaP and Tdap Vaccines Product Offered

Table 145. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. AstraZeneca Main Business

Table 147. AstraZeneca Latest Developments

Table 148. Emergent BioSolutions Inc Basic Information, DTaP and Tdap Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 149. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Offered

Table 150. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Emergent BioSolutions Inc Main Business

Table 152. Emergent BioSolutions Inc Latest Developments

List of Figures

Figure 1. Picture of DTaP and Tdap Vaccines

Figure 2. DTaP and Tdap Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global DTaP and Tdap Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global DTaP and Tdap Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. DTaP and Tdap Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of DTaP

Figure 10. Product Picture of Td

Figure 11. Product Picture of Tdap

Figure 12. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2021

Figure 13. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. DTaP and Tdap Vaccines Consumed in Adult

Figure 15. Global DTaP and Tdap Vaccines Market: Adult (2017-2022) & (K Units)

Figure 16. DTaP and Tdap Vaccines Consumed in Pediatric

Figure 17. Global DTaP and Tdap Vaccines Market: Pediatric (2017-2022) & (K Units)

Figure 18. Global DTaP and Tdap Vaccines Sales Market Share by Application (2017-2022)

Figure 19. Global DTaP and Tdap Vaccines Revenue Market Share by Application in 2021

Figure 20. DTaP and Tdap Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 21. Global DTaP and Tdap Vaccines Revenue Market Share by Company in 2021

Figure 22. Global DTaP and Tdap Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global DTaP and Tdap Vaccines Revenue Market Share by Geographic Region in 2021

Figure 24. Global DTaP and Tdap Vaccines Sales Market Share by Region (2017-2022)

Figure 25. Global DTaP and Tdap Vaccines Revenue Market Share by Country/Region in 2021

Figure 26. Americas DTaP and Tdap Vaccines Sales 2017-2022 (K Units)

Figure 27. Americas DTaP and Tdap Vaccines Revenue 2017-2022 ($ Millions)

Figure 28. APAC DTaP and Tdap Vaccines Sales 2017-2022 (K Units)

Figure 29. APAC DTaP and Tdap Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. Europe DTaP and Tdap Vaccines Sales 2017-2022 (K Units)

Figure 31. Europe DTaP and Tdap Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa DTaP and Tdap Vaccines Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa DTaP and Tdap Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Americas DTaP and Tdap Vaccines Sales Market Share by Country in 2021

Figure 35. Americas DTaP and Tdap Vaccines Revenue Market Share by Country in 2021

Figure 36. United States DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC DTaP and Tdap Vaccines Sales Market Share by Region in 2021

Figure 41. APAC DTaP and Tdap Vaccines Revenue Market Share by Regions in 2021

Figure 42. China DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. India DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe DTaP and Tdap Vaccines Sales Market Share by Country in 2021

Figure 49. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2021

Figure 50. Germany DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. France DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Country in 2021

Figure 56. Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share by Country in 2021

Figure 57. Egypt DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country DTaP and Tdap Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of DTaP and Tdap Vaccines in 2021

Figure 63. Manufacturing Process Analysis of DTaP and Tdap Vaccines

Figure 64. Industry Chain Structure of DTaP and Tdap Vaccines

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles